Statland, J., Campbell, C., Desai, U., Karam, C., Diaz-Manera, J., Guptill, J., . . . Attie, K. (2022). Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.
Citación estilo ChicagoStatland, JM, et al. Randomized Phase 2 Study of ACE-083, a Muscle-promoting Agent, in Facioscapulohumeral Muscular Dystrophy. 2022.
Cita MLAStatland, JM, et al. Randomized Phase 2 Study of ACE-083, a Muscle-promoting Agent, in Facioscapulohumeral Muscular Dystrophy. 2022.
Precaución: Estas citas no son 100% exactas.